US Patent

US11707466 — Immediate release multilayer tablet

Formulation · Assigned to Alkermes Pharma Ireland Ltd · Expires 2041-11-12 · 15y remaining

Vulnerability score 50/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects an immediate release multilayer tablet for orally delivering olanzapine and samidorphan.

USPTO Abstract

Described herein, in part, are tablets, such as immediate release multi-layer or bilayer tablets for orally delivering olanzapine and samidorphan, methods of using said tablets in the treatment of disorders described herein, and kits comprising said tablets.

Drugs covered by this patent

Patent Metadata

Patent number
US11707466
Jurisdiction
US
Classification
Formulation
Expires
2041-11-12
Drug substance claim
No
Drug product claim
Yes
Assignee
Alkermes Pharma Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.